Chemoinformaics analysis of 1,4-Diethylbenzene
| Molecular Weight | 134.222 | nRot | 2 |
| Heavy Atom Molecular Weight | 120.11 | nRig | 7 |
| Exact Molecular Weight | 134.11 | nRing | 1 |
| Solubility: LogS | -6.609 | nHRing | 0 |
| Solubility: LogP | 7.835 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 0 | APOL | 26.0351 |
| nHD | 0 | BPOL | 14.0449 |
| QED | 0.258 |
| Synth | 3.383 |
| Natural Product Likeliness | 1.149 |
| NR-PPAR-gamma | 0.442 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.022 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.829 |
| MDCK | 0.0000144 |
| BBB | 0.115 |
| PPB | 0.982324 |
| VDSS | 1.014 |
| FU | 0.0177645 |
| CYP1A2-inh | 0.091 |
| CYP1A2-sub | 0.167 |
| CYP2c19-inh | 0.282 |
| CYP2c19-sub | 0.482 |
| CYP2c9-inh | 0.119 |
| CYP2c9-sub | 0.874 |
| CYP2d6-inh | 0.075 |
| CYP2d6-sub | 0.028 |
| CYP3a4-inh | 0.706 |
| CYP3a4-sub | 0.076 |
| CL | 7.004 |
| T12 | 0.089 |
| hERG | 0.057 |
| Ames | 0.003 |
| ROA | 0.008 |
| SkinSen | 0.948 |
| Carcinogencity | 0.04 |
| EI | 0.27 |
| Respiratory | 0.037 |
| NR-Aromatase | 0.162 |
| Antiviral | No |
| Prediction | 0.905742 |